According to the World Health Organization (WHO) classification of digestive system tumors (5th edition, 2019)3, AFPGC is characterized as a rare type of GC with elevated serum AFP levels and positive immunohistochemistry (IHC) staining for AFP, accounting for 1.3–5.4% of GC4–7. This evidence concerns the gene AFP and gastric cancer.